Immunogen Inc
IMGN
IMGN was delisted on the 9th of February, 2024.
141 hedge funds and large institutions have $665M invested in Immunogen Inc in 2015 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 54 increasing their positions, 33 reducing their positions, and 18 closing their positions.
155% more call options, than puts
Call options by funds: $7.88M | Put options by funds: $3.1M
67% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 18
64% more repeat investments, than reductions
Existing positions increased: 54 | Existing positions reduced: 33
57% more capital invested
Capital invested by funds: $423M → $665M (+$242M)
8% more funds holding
Funds holding: 131 → 141 (+10)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ClearBridge Investments
New York
|
+$21.8M |
| 2 |
State Street
Boston,
Massachusetts
|
+$7.89M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$7.24M |
| 4 |
Primecap Management
Pasadena,
California
|
+$3.49M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$3.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$4.71M |
| 2 |
Millennium Management
New York
|
-$3.98M |
| 3 |
BB
BB Biotech
Schaffhausen,
Switzerland
|
-$2.9M |
| 4 |
D.E. Shaw & Co
New York
|
-$2.81M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.37M |
IMGN Hedge Fund Activity: Q1 2015 in Review
141 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q1 2015, worth a combined $665M — up 57% from $423M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new IMGN positions and 18 closed out — a net gain of 12 holders — while 54 added to existing stakes and 33 trimmed.
The largest buyer was ClearBridge Investments, adding an estimated $21.8M. The largest seller was Bogle Investment Management, exiting entirely with an estimated $4.71M sold.
- 141 institutional investors held Immunogen Inc (IMGN) as of Q1 2015, up from 131 in Q4 2014.
- Funds reported $665M of Immunogen Inc stock for Q1 2015, up 57% quarter-over-quarter.
- 30 funds opened new Immunogen Inc positions in Q1 2015 and 18 closed out, a net change of +12 holders.
- The largest Immunogen Inc buyer in Q1 2015 was ClearBridge Investments, an estimated $21.8M added.
- The largest Immunogen Inc seller in Q1 2015 was Bogle Investment Management, an estimated $4.71M sold.
Based on aggregated 13F filings for Q1 2015.